Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravitreal triamcinolone acetonide dose comparison in diabetic macular edema
ACTRN12613000249752Phase 4Completed
- Sponsor
- Suez Canal University Hospital
- Start
- Mar 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of triamcinolone acetonide in diabetic macular edema (DME) (2 arms), sponsored by Suez Canal University Hospital. Primary endpoint: Control of diabetic macular edema. Started Mar 2010; status: completed.
02
Drugs
triamcinolone acetonide
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on ACTRN12613000249752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613000249752.